06/10/2026 | Press release | Distributed by Public on 06/10/2026 15:14
|
FORM 4
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|
|||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) | ||
|
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) |
4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Employee Stock Option (right to purchase) | $0.57 | (5) | 09/18/2033 | Common Stock | 4,150,347 | 4,150,347(1) | D | ||||||||
| Restricted Stock Units | (6) | (7) | (7) | Common Stock | 2,421,971 | 2,421,971 | D | ||||||||
| Earnout Shares | (8) | (8) | 01/13/2030 | Common Stock | 1,371,303 | 1,371,303 | D | ||||||||
| Employee Stock Option (right to purchase) | $1.18 | (9) | 10/23/2034 | Common Stock | 5,755,192 | 5,755,192 | D | ||||||||
| Employee Stock Option (right to purchase) | $1.29 | (10) | 03/15/2027 | Common Stock | 114,650 | 114,650 | D | ||||||||
| Employee Stock Option (right to purchase) | $14.62 | (10) | 11/12/2028 | Common Stock | 176,503 | 176,503 | D | ||||||||
| Reporting Owner Name / Address | Relationships | |||
| Director | 10% Owner | Officer | Other | |
|
Munagala Dinakar C/O BLAIZE HOLDINGS, INC. 4659 GOLDEN FOOTHILL PARKWAY, SUITE 206 EL DORADO HILLS, CA 95762 |
X | Chief Executive Officer | ||
| /s/ Harminder Sehmi, as Attorney-in-Fact | 06/10/2026 | |
| **Signature of Reporting Person | Date |
| * | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
| ** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| (1) | On April 20, 2026, the reporting person filed a Form 4 (the "Original Form 4") which inadvertently reported that the reporting person exercised a stock option and sold the underlying stock. Instead, as reported in this amendment (this "Amendment"), the reporting person did not exercise the stock option and in fact sold the same number of shares of stock as originally reported in the Original Form 4 but from his Table I holdings. The reporting person's other holdings have been restated for convenience, and there have been no transactions in such holdings since the Original Form 4. The order of the footnotes in this Explanation of Responses section have been conformed to the above changes. |
| (2) | The reported sales were effected pursuant to the reporting person's Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2025. |
| (3) | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.63, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
| (4) | In the reporting person's prior Form 4 filings, earnout shares and unvested restricted stock units had been reported in Table I. These holdings have been moved to Table II, and there have been no transactions in such holdings since the reporting person's last Form 4 filing. |
| (5) | The stock option vests in 36 substantially equal monthly installments beginning on October 19, 2023. |
| (6) | Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
| (7) | The restricted stock units vest 25% on December 1, 2027, and quarterly thereafter commencing on March 1, 2028. |
| (8) | On January 13, 2025, the date of the Issuer's business combination, the reporting person received earnout shares in respect of the Issuer's business combination. Each eanout share represents a contingent right to receive one share of the Issuer's common stock if the trading price of the Issuer's common stock exceeds certain thresholds for 20 of 30 consecutive trading days post-closing of the Issuer's business combination. |
| (9) | The stock option vests as to one third of the underlying shares on July 1, 2025 and thereafter in 24 equal monthly installments. |
| (10) | The stock option to purchase one share of the Issuer's common stock for each stock option is fully vested and exercisable. |